Warrants of series TO 7 were exercised to approximately 83 percent and Smoltek receives approximately SEK 7.2 million
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTION THAN WHAT IS REQUIRED UNDER SWEDISH LAW.
Smoltek Nanotech Holding AB (publ) ("Smoltek" or "the Company") today announces the outcome of the exercise of warrants of series TO 7, which were issued in connection with the Company’s rights issue of units on Spotlight Stock Market in November 2022. In total, 2,033,315 warrants of series TO 7 were exercised, corresponding to approximately 83 percent of the total number of outstanding warrants of series TO 7, for subscription of 2,033,315 new shares at a subscription price of SEK 3.56 per share. Smoltek will receive approximately SEK 7.2 million before issuing costs through the exercise of the warrants of series TO 7, which are estimated to amount to approximately SEK 0.3 million.
“I would like to extend a big thank you to the shareholders who used their warrants. Thanks to this, we receive an additional cash injection to continue the development of our technology for ultra-thin capacitors and cell material to electrolyzers, and to further prepare Smoltek for commercialization in these two business areas. We are convinced of Smoltek's great potential and see an exciting development ahead for the company."
Håkan Persson, CEO of Smoltek Nanotech Holding AB.
Background
The subscription period for the exercise of warrants of series TO 7 for subscription of new shares in the Company ran from and including June 5, 2023, to and including June 19, 2023. The exercise price per new share when exercising the warrants of series TO 7 was SEK 3.56.
Number of shares, share capital and dilution
Through the exercise of the warrants of series TO 7, the share capital increases by SEK 242,225.262640, from SEK 1,690,297.312587 to SEK 1,932,522.575227, and the number of shares increases by 2,033,315, from 14,188,887 shares to 16,222,202 shares. For existing shareholders who have not exercised any warrants of series TO 7, the dilution amounts to approximately 12.5 percent of the total number of shares and voting rights in the Company.
Delivery of subscribed shares
Subscribers of new shares through the exercise of warrants of series TO 7 receive interim shares (IA) pending registration of the new shares with the Swedish Companies Registration Office. The conversion of interim shares into shares is estimated to occur within approximately three (3) weeks.
Advisers
Mangold Fondkommission AB is financial adviser and MAQS Advokatbyrå AB is legal adviser for the Company in connection with the subscription of the warrants of series TO 7.
For further information
Håkan Persson, CEO of Smoltek Nanotech Holding AB
E-mail: hakan.persson@smoltek.com
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors
About Smoltek
Smoltek is a Swedish technology company based in Gothenburg, specialized in the development and integration of carbon nanotechnology. The technology is used in the manufacture of highly conductive vertical carbon nanostructures to create a three-dimensional surface in various precision-defined patterns, in order to solve advanced materials engineering challenges in the process and semiconductor industry. Today, Smoltek is focus on enabling the potential of the continuous miniaturization in the semiconductor industry and the development of green energy production in the hydrogen industry.
In the semiconductor business area, the Company develops ultra-thin capacitors, where the first model is so-called 'decoupling capacitors' intended to support application processors in mobile phones. In the hydrogen business area, the first product is planned to be a new carbon nano-based cell material intended for use in PEM electrolyzers to radically reduce investment cost for production of fossil-free hydrogen.
Smoltek's technology makes components and materials thinner, more energy efficient, more powerful, and cheaper. This is made possible by the three-dimensional surface structure of the carbon nanostructures, which creates a surface that can be refined multiple times in the same volume for, for example, electrical and chemical processes. Smoltek has a strong patent-protected technology consisting of roughly 110 patent assets within 20 patent families, of which 79 are currently granted patents. The company's stock is listed on the Spotlight Stock Market. For more information, go to www.smoltek.com/investors.
Important information
Publication, disclosure, or distribution of this press release may in certain jurisdictions be subject to restrictions by law, and persons in jurisdictions where this press release has been published or distributed should inform themselves about and comply with such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in their respective jurisdiction. This press release does not constitute an offer to acquire or subscribe for any securities in Smoltek in any jurisdiction, neither from Smoltek nor from any other party.
This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration or without the application of an exemption from registration under the U.S. Securities Act of 1933 ("Securities Act"), and may not be offered or sold in the United States unless they are registered, exempt from, or in a transaction not subject to the registration requirements under the Securities Act. There is no intention to register any securities mentioned herein in the United States or to make a public offer regarding such securities in the United States. The information in this press release may not be disclosed, published, copied, reproduced, or distributed, directly or indirectly, in whole or in part, in or into Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, South Africa, the United States, Belarus, Russia, or any other jurisdiction where such disclosure, publication, or distribution of this information would contravene applicable regulations or where such action is subject to legal restrictions or would require additional registration or other measures beyond what is required under Swedish law. Actions in violation of this instruction may constitute a breach of applicable securities laws.